Testing effectiveness (Phase 2)Study completedNCT02907099
What this trial is testing
Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer
Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
M.D. Anderson Cancer Center 20